Prelude Capital Management, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Prelude Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $129,425 - $165,450	-2,500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $92,625 - $162,575	2,500 New	2,500 $149,000
Q3 2019 Nov 14, 2019	SELL	$19.95 - $38.85 $5,306 - $10,334	-266 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$21.05 - $26.21 $3,999 - $4,979	190 Added 250.0%	266 $6,000
Q1 2019 May 15, 2019	BUY	$20.65 - $29.55 $1,569 - $2,245	76 New	76 $2,000
Q4 2017 Feb 14, 2018	SELL	$16.54 - $24.2 $26,679 - $39,034	-1,613 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$17.65 - $18.99 $28,469 - $30,630	1,613	1,613 $31,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.